Sounds like that might’ve been the case with multiple partners. Nasrat specifically called out ones like TAGI, made it sound like they pull their weight and maybe we want to keep some of those arrangements in place.
Good to have a lot of our drugs being sold on our label by Kirko, sounds like he’s able to squeeze out more $ on both our larger and smaller generics.
News 
Market Data 
Discover 
